TLR6 and metabolic dysfunction-associated steatohepatitis: Indeed, TLR6 deregulation found in NAFL and NASH patients seems to contribute to the worsening of liver inflammation, and has been pointed out as a potential peripheral biomarker of NASH severity [76].